Stay updated on Combination Immunotherapy for Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Combination Immunotherapy for Prostate Cancer Clinical Trial page.

Latest updates to the Combination Immunotherapy for Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew documents and IPD sharing details were added to the study record, including the Informed Consent Form, Study Protocol and SAP, and the IPD Sharing Plan with access criteria and time frame. It also references the NIH Clinical Center and NCI personnel, providing context on the study's governance and transparency.SummaryDifference91%

- Check21 days agoChange DetectedA new revision tag Revision: v3.6.5 was added. The related topics/keywords including Prostate cancer and MedlinePlus Genetics, as well as the prior Revision: v3.6.4 text, were removed.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page now includes updated topic tags: Prostate cancer and related topics, with a link to MedlinePlus Genetics. This reflects the study’s disease focus and provides quick access to educational resources.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page’s revision tag was updated from v3.6.3 to v3.6.4. This indicates a minor update to the site’s underlying assets or rendering, with no visible content changes indicated.SummaryDifference0.0%

- Check42 days agoChange Detected"Prostate cancer" topic label and the "related topics: MedlinePlus Genetics" section were removed from the study details page. This changes how the trial is categorized and navigated for users seeking information on prostate cancer trials and related educational resources.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded related topics: Prostate cancer and MedlinePlus Genetics to the page to connect users with topic-specific resources.SummaryDifference0.1%

Stay in the know with updates to Combination Immunotherapy for Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Immunotherapy for Prostate Cancer Clinical Trial page.